5-溴-2-碘苯酚 | 858855-11-5

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物 - 酚及其卤化、磺化、硝化或亚硝化衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 5-溴-2-碘苯酚
• 英文名称: 5-bromo-2-iodophenol
• CAS: 858855-11-5
• 化学式: C₆H₄BrIO
• 分子量: 298.906
• InChiKey: KGVIGGKRRGGQMM-UHFFFAOYSA-N

物化性质

• 熔点：
  55 °C
• 沸点：
  239.4±20.0 °C(Predicted)
• 密度：
  2.369±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2908199090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-bromo-2-iodophenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-bromo-2-iodophenol
CAS number: 858855-11-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H4BrIO
Molecular weight: 298.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-溴-2-碘苯酚 在 盐酸 、 四(三苯基膦)钯 、 sodium azide 、 18-冠醚-6 、 三正丁胺 、 palladium diacetate 、 potassium carbonate 、 三苯基膦 、 三(邻甲基苯基)磷 、 potassium iodide 作用下， 以 四氢呋喃 、 甲醇 、 水 、 二甲基亚砜 、 丙酮 、 甲苯 为溶剂， 反应 76.0h， 生成
  参考文献：
  名称：

  寡聚苯撑乙烯化合物及其制备方法和应用

  摘要：

  本发明涉及抗肿瘤药物领域，公开了一种寡聚苯撑乙烯化合物及其制备方法和应用。本发明提供的寡聚苯撑乙烯化合物具有如式(3)所示的结构，其中，n为2‑10的整数。本发明提供的结构如式(3)所示的化合物具有良好的抑制肿瘤细胞增殖的作用，特别是对耐药肿瘤细胞的增殖也具有良好的抑制作用，但对正常细胞的毒副作用较小。

  公开号：

  CN107382786B
• 作为产物：
  描述：

  间溴苯酚 在 potassium iodate 、 硫酸 、 potassium iodide 作用下， 以 水 为溶剂， 反应 24.0h， 以47%的产率得到5-溴-2-碘苯酚
  参考文献：
  名称：

  杂原子桥连环状二芳基碘鎓盐的一锅法合成

  摘要：

  描述了构建O-和N-桥联二芳基碘鎓三氟甲磺酸盐的两个一锅法。邻碘苯酚和磺酰胺的有效芳基介导的芳基化提供二芳基醚和二芳基胺中间体，它们随后被氧化并环化为相应的二芳基碘代辛鎓和-碘嗪鎓盐。应用了不同的衍生方法来证明它们作为有用的构建块的能力，并对这些未开发但可能非常有用的化合物的一般反应性有更深入的了解。

  DOI：

  10.1021/acs.orglett.2c00691

文献信息

• [EN] FUSED TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE<br/>[FR] COMPOSÉS TRYCICLIQUES CONDENSÉS ET UTILISATIONS CORRESPONDANTES EN MÉDECINE
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2018219356A1

  公开（公告）日：2018-12-06

  The present invention relates to a fused tricyclic compound and use thereof as a medicament, in particular as a medicament for the treatment and/or prevention of hepatitis B. Specifically, the invention relates to a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variate is as defined in specification. The invention also relates to the use of the compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.

  本发明涉及一种融合三环化合物及其作为药物的用途，特别是作为治疗和/或预防乙型肝炎的药物。具体地，本发明涉及具有化学式（I）或其立体异构体、互变异构体、N-氧化物、溶剂合物、代谢物、药学上可接受的盐或其前药的化合物，其中每个变量如规范中所定义。本发明还涉及将具有化学式（I）或其立体异构体、互变异构体、N-氧化物、溶剂合物、代谢物、药学上可接受的盐或其前药用作药物，特别是作为治疗和/或预防乙型肝炎的药物。
• <i>Ortho</i>-Stabilized¹⁸F-Azido Click Agents and their Application in PET Imaging with Single-Stranded DNA Aptamers
  作者：Lu Wang、Orit Jacobson、Din Avdic、Benjamin H. Rotstein、Ido D. Weiss、Lee Collier、Xiaoyuan Chen、Neil Vasdev、Steven H. Liang

  DOI：10.1002/anie.201505927

  日期：2015.10.19

  versatile building blocks for the radiolabeling of biomolecules via Huisgen cycloaddition (“click chemistry”) for positron emission tomography (PET). However, routine access to such clickable agents is challenged by inefficient and/or poorly defined multistep radiochemical approaches. A high‐yielding direct radiofluorination for azido 18F‐arenes was achieved through the development of an ortho‐oxygen‐stabilized

  叠氮基18 F-芳烃是通过正电子发射断层扫描 (PET) 的 Huisgen 环加成（“点击化学”）对生物分子进行放射性标记的重要且通用的构建模块。然而，对此类可点击试剂的常规获取受到低效和/或定义不明确的多步骤放射化学方法的挑战。通过开发邻位氧稳定的碘鎓衍生物（OID），实现了叠氮基18 F-芳烃的高产率直接放射性氟化。该 OID 策略解决了对用于生物共轭反应的可靠叠氮基18 F-芳烃可点击试剂的未满足需求。使用该试剂对 ssDNA 适体进行放射性标记，并通过 PET 在人类结肠癌的异种移植小鼠模型中进行可视化，这表明这种 OID 方法是一种方便且高效的标记和跟踪生物分子的方法。
• [EN] 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA 3-PHOSPHOGLYCÉRATE DÉSHYDROGÉNASE ET LEURS UTILISATIONS
  申请人：RAZE THERAPEUTICS INC

  公开号：WO2017156165A1

  公开（公告）日：2017-09-14

  The present invention provides compounds, compositions thereof, and methods of using the same.

  本发明提供了化合物、其组合物以及使用这些化合物的方法。
• [EN] COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS<br/>[FR] ASSOCIATIONS D'INHIBITEURS DU VIRUS DE L'HÉPATITE C
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2015005901A1

  公开（公告）日：2015-01-15

  The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

  本公开涉及抗病毒化合物，更具体地涉及能够抑制由丙型肝炎病毒（HCV）编码的NS5A蛋白功能的化合物组合，包括这种组合的组合物，以及抑制NS5A蛋白功能的方法。
• Hepatitis C Virus Inhibitors
  申请人：Bristol-Myers Squibb Company

  公开号：US20130183269A1

  公开（公告）日：2013-07-18

  The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

  本公开涉及抗病毒化合物，更具体地涉及能够抑制丙型肝炎病毒（HCV）编码的NS5A蛋白功能的化合物组合，包括这种组合的组成物，以及抑制NS5A蛋白功能的方法。